LCM
WVE icon

Laurion Capital Management’s Wave Life Sciences WVE Stock Holding History

Laurion Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-516,473
Closed -$2.58M – 619
2024
Q2 		$2.58M Sell
516,473
-355,027
-41% -$2.03M 0.03% 201
2024
Q1 		$5.38M Sell
871,500
-200,000
-19% -$1M 0.05% 246
2023
Q4 		$5.41M Buy
1,071,500
+200,000
+23% +$1.07M 0.05% 241
2023
Q3 		$5.01M Buy
871,500
+42,662
+5% +$195K 0.03% 282
2023
Q2 		$3.02M Sell
828,838
-42,662
-5% -$172K 0.02% 287
2023
Q1 		$3.77M Hold
871,500
– – 0.03% 249
2022
Q4 		$6.1M Hold
871,500
– – 0.03% 254
2022
Q3 		$3.15M Hold
871,500
– – 0.02% 291
2022
Q2 		$2.83M Buy
+871,500
New +$1.68M 0.04% 204

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Laurion Capital Management's WVE Position: Q3 2024 in Review

Laurion Capital Management sold out of Wave Life Sciences (WVE) in Q3 2024, closing a stake of 516,473 shares — an estimated $2.58M sold.

Laurion Capital Management first reported a position in WVE in Q2 2022 and held it in 9 quarters. The position peaked at $6.1M in Q4 2022. 162 funds tracked by Wall St. Rank hold WVE as of Q3 2024.

  • Laurion Capital Management reported no remaining Wave Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 516,473 Wave Life Sciences shares in Q3 2024, an estimated $2.58M.
  • Laurion Capital Management first reported a position in Wave Life Sciences in Q2 2022 and held it in 9 quarters.
  • Laurion Capital Management's Wave Life Sciences position peaked at $6.1M in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.